Remove Hospitals Remove Physician Offices Remove Specialty Pharmacies
article thumbnail

Out of Shortage, Into Controversy: The Fight Over GLP-1 Compounding

Pharmacy Times

All of this is in the face of yet another round of manufacturer cease-and-desist letters to compounding pharmacies and even physician offices demanding they cease all compounding, dispensing, and sale of compounded GLP-1s. 5 The difference is significant, as biologics cannot be compounded.

article thumbnail

Specialty Pharmacy Keeps Disrupting Buy-and-Bill—and COVID-19 Will Accelerate It

Drug Channels

Will COVID-19 trigger long-term share gains for specialty pharmacies as suppliers to hospitals and physician offices? But payers will try to retain some of these gains—especially if they also own a specialty pharmacy. See below for detailed data on oncology and non-oncology products.

article thumbnail

Specialty Pharmacy Keeps Disrupting Buy-and-Bill—and COVID-19 Will Accelerate It (rerun)

Drug Channels

Will COVID-19 trigger long-term share gains for specialty pharmacies as suppliers to hospitals and physician offices? But payers will try to retain some of these gains—especially if they also own a specialty pharmacy. Click here to see the original post and comments from September 2020.